title: Successful cholecystectomy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria during eculizumab treatment.
authors: Keiko
authors: K
authors: Ando
authors: Akihiko
authors: A
authors: Gotoh
authors: Seiichiro
authors: S
authors: Yoshizawa
authors: Moritaka
authors: M
authors: Gotoh
authors: Tamiko
authors: T
authors: Iwabuchi
authors: Yoshikazu
authors: Y
authors: Ito
authors: Kazuma
authors: K
authors: Ohyashiki
mesh_terms: D000741:Anemia, Aplastic / Q000209:etiology / Q000517:prevention & control*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D002763:Cholecystectomy / Q000009:adverse effects; D041881:Cholecystitis, Acute / Q000209:etiology / Q000601:surgery; D017707:Erythrocyte Transfusion; D005260:Female; D006457:Hemoglobinuria, Paroxysmal / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D060046:Maintenance Chemotherapy / Q000009:adverse effects; D009894:Opportunistic Infections / Q000503:physiopathology; D012008:Recurrence; D000267:Tissue Adhesions / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; C481642:eculizumab